Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

167
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
167
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Introduction to Epidemiology01:26

Introduction to Epidemiology

663
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
663
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

83
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

148
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in mortality of people on dialysis in England and Wales over the last 15 years.

QJM : monthly journal of the Association of Physicians·2026
Same author

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same author

Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study.

EBioMedicine·2026
Same author

Machine learning for identifying caregiving adversities associated with greatest risk for mental health problems in children.

Nature. Mental health·2026
Same author

Bracing Research in Idiopathic Scoliosis.

Studies in health technology and informatics·2026
Same author

Rate of decline in residual kidney function and cognitive impairment in incident haemodialysis patients: A prospective, longitudinal analysis of the BISTRO trial cohort.

PloS one·2026

Related Experiment Video

Updated: Jun 11, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis.

Jeremy P Brown1,2, Jacob N Hunnicutt3, M Sanni Ali2

  • 1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Pharmacoepidemiology and Drug Safety
|October 8, 2024
PubMed
Summary
This summary is machine-generated.

Quantitative bias analyses help assess the reliability of pharmacoepidemiological studies by quantifying potential residual biases from unmeasured confounders, measurement error, or selection bias.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

448
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Related Experiment Videos

Last Updated: Jun 11, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

448
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Area of Science:

  • Pharmacoepidemiology
  • Biostatistics
  • Health Research Methods

Background:

  • Pharmacoepidemiological studies are crucial for evaluating medication safety and effectiveness.
  • Study validity can be compromised by residual biases, such as unmeasured confounding, measurement error, or selection bias.
  • Existing methods may not fully address these persistent biases.

Purpose of the Study:

  • To introduce quantitative bias analyses (QBAs) as a method to assess the robustness of pharmacoepidemiological study findings.
  • To explain how QBAs quantitatively and transparently evaluate the impact of residual biases.
  • To focus on the application of QBAs for unmeasured confounding, misclassification, and selection bias in this field.

Main Methods:

  • Quantitative Bias Analyses (QBAs) are presented as a suite of methods.
  • These methods involve specifying assumptions about potential biases to quantify their impact on effect estimates.
  • Specific techniques for assessing unmeasured confounding, misclassification, and selection bias are discussed.

Main Results:

  • QBAs provide a transparent framework for assessing the sensitivity of study results to potential biases.
  • The methods allow for the calculation of bounds on effect estimates under various bias scenarios.
  • Application of QBAs can strengthen the interpretation of pharmacoepidemiological findings.

Conclusions:

  • Quantitative bias analyses are essential tools for enhancing the validity of pharmacoepidemiological research.
  • These methods offer a robust approach to address residual biases that may remain after standard statistical adjustments.
  • Implementing QBAs improves the reliability and trustworthiness of evidence on medication safety and effectiveness.